Western Europe Australia Middle East Central America Africa South America Asia Eastern Europe North America
Product Description
Adcapon - comtan® (entacapone) is available as tablets containing 200-mg adcapon. Comtan (entacapone) is indicated as an adjunct to levodopa/carbidopa to treat patients with idiopathic parkinson's disease who experience the signs and symptoms of end-of-dose "wearing-off" (see clinical pharmacology, clinical studies). Comtan's effectiveness has not been systematically evaluated in patients with idiopathic parkinson's disease who do not experience end-of-dose "wearing-off". Active ingredients: entacapone